meglumine has been researched along with Brain Ischemia in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Liu, Y; Tian, J; Wang, Y; Xie, P; Xu, J; Yan, L; Zhao, L; Zhao, Y | 1 |
| Cai, J; Lei, A; Liang, F; Zhang, J; Zhang, Y | 1 |
| Cao, L; Cao, ZY; Hu, HF; Luo, YP; Wang, ZZ; Xiao, W; Zhang, H; Zhang, XZ | 1 |
| Cao, L; Cao, ZY; Ke, ZP; Li, ZQ; Wang, ZZ; Xiao, W | 1 |
| Gao, Y; Lai, XX; Tan, ZH; Wang, Y; Xu, TS; Yu, M; Zhao, JJ; Zhou, L | 1 |
| Ellingson, B; Finn, P; Liebeskind, DS; Meshksar, A; Nael, K; Pirastehfar, M; Salamon, N; Villablanca, JP | 1 |
| Faĭzullin, RM; Kalugina, AV; Malkin, MP; Miroshnichenko, II; Priakhina, KE; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Forsting, M; Heiland, S; Reith, W; Sartor, K; Vogler, H | 1 |
| Ide, H; Ishii, Y; Itoh, S; Kobayashi, H; Kubota, T; Maeda, M; Matsuda, T | 1 |
| Egelhof, T; Essig, M; Sartor, K; von Kummer, R; Winter, R | 1 |
| La Noce, A; Miragoli, L; Samuelli, G; Tirone, P | 1 |
| Demicheli, F; Frigeni, V; La Noce, A; Miragoli, L; Tirone, P | 1 |
| O'Regan, MH; Phillis, JW; Song, D | 1 |
| Frigeni, V; Grotti, A; Lorusso, V; Miragoli, L | 1 |
| Frigeni, V; Grotti And, A; Lorusso, V; Miragoli, L | 1 |
| Mirowitz, SA | 1 |
| Bhatti, SU; Crumrine, RC; Finelli, DA; Hopkins, AL; Lust, WD; Selman, WR | 1 |
| Edelman, RR; Li, W; Ronthal, M; Warach, S | 1 |
1 trial(s) available for meglumine and Brain Ischemia
| Article | Year |
|---|---|
Use of Diterpene Ginkgolides Meglumine Injection to Regulate Plasma Levels of PAI-1 and t-PA in Patients With Acute Atherosclerotic Cerebral Infarction.
Topics: Acute Disease; Brain Ischemia; Cerebral Infarction; Fibrinolysis; Ginkgolides; Humans; Meglumine; Plasminogen Activator Inhibitor 1; Stroke; Tissue Plasminogen Activator | 2022 |
17 other study(ies) available for meglumine and Brain Ischemia
| Article | Year |
|---|---|
Adoption of Magnetic Resonance Image Features under Segmentation Algorithm in Effect Evaluation of Ginkgo Diterpenoid Lactone Glucamine Injection in Treatment of Cerebral Infarction.
Topics: Algorithms; Brain Ischemia; Cerebral Infarction; Diterpenes; Ginkgo biloba; Humans; Image Processing, Computer-Assisted; Lactones; Magnetic Resonance Imaging; Meglumine; Vascular Endothelial Growth Factor A | 2022 |
[Protective effects of Ginkgo Terpene Lactones Meglumine Injection on focal cerebral ischemia in rats].
Topics: Animals; Aspartic Acid; Brain Ischemia; Calcium; Creatine Kinase, BB Form; Ginkgo biloba; Glutamic Acid; Glutathione; L-Lactate Dehydrogenase; Lactic Acid; Lactones; Male; Malondialdehyde; Meglumine; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase; Terpenes | 2017 |
[Cerebral vascular protective effect of ginkgo diterpene lactone meglumine injection].
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Diterpenes; Ginkgo biloba; Infarction, Middle Cerebral Artery; Lactones; Matrix Metalloproteinase 9; Meglumine; Rats | 2017 |
[Post-marketing study on clinical safety of ginkgo diterpene lactone meglumine injection in 6 300 patients with ischemic stroke].
Topics: Brain Ischemia; Diterpenes; Drugs, Chinese Herbal; Ginkgo biloba; Humans; Lactones; Meglumine; Product Surveillance, Postmarketing; Prospective Studies; Stroke | 2017 |
Combined low-dose contrast-enhanced MR angiography and perfusion for acute ischemic stroke at 3T: A more efficient stroke protocol.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Brain Ischemia; Cerebral Arteries; Contrast Media; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Radiation Dosage; Radiation Protection; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stroke; Time Factors | 2014 |
[The effect of 3-oxypyridine and succinic acid derivatives on the resistance to acute cerebral ischemia].
Topics: Acute Disease; Animals; Brain Ischemia; Disease Models, Animal; Female; Male; Meglumine; Mice; Picolines; Pyridines; Succinates; Thioctic Acid | 2014 |
Early MR detection of experimentally induced cerebral ischemia using magnetic susceptibility contrast agents: comparison between gadopentetate dimeglumine and iron oxide particles.
Topics: Animals; Blood Volume; Brain Ischemia; Capillary Permeability; Cerebral Angiography; Cerebrovascular Circulation; Contrast Media; Disease Models, Animal; Drug Combinations; Ferric Compounds; Gadolinium; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Magnetics; Male; Meglumine; Microcirculation; Microradiography; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar | 1995 |
Acute stroke in cats: comparison of dynamic susceptibility-contrast MR imaging with T2- and diffusion-weighted MR imaging.
Topics: Acute Disease; Animals; Blood Volume; Brain Ischemia; Cats; Cerebral Cortex; Cerebrovascular Circulation; Cerebrovascular Disorders; Contrast Media; Diffusion; Drug Combinations; Gadolinium; Gadolinium DTPA; Hemodynamics; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Time Factors | 1993 |
Vascular MR contrast enhancement in cerebrovascular disease.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Ischemia; Carotid Artery, Internal; Carotid Stenosis; Cerebral Angiography; Cerebral Arteries; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; Collateral Circulation; Contrast Media; Drug Combinations; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1996 |
An experimental study on the neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Contrast Media; Drug Combinations; Evoked Potentials, Visual; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley | 1996 |
Neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia: EEG evaluation.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Contrast Media; Electroencephalography; Gadolinium; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Rats | 1999 |
Effects of hyperosmolarity and ion substitutions on amino acid efflux from the ischemic rat cerebral cortex.
Topics: Animals; Blood Gas Analysis; Blood Pressure; Brain Edema; Brain Ischemia; Cerebral Cortex; Chlorides; Choline; Diuretics, Osmotic; Electroencephalography; gamma-Aminobutyric Acid; Gluconates; Glutamic Acid; Hydrogen-Ion Concentration; Male; Mannitol; Meglumine; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Sodium; Sucrose; Taurine; Water-Electrolyte Balance | 1999 |
Neurotolerability of contrast agents in rats with brain ischemia induced by transient middle cerebral artery occlusion: EEG evaluation.
Topics: Animals; Arterial Occlusive Diseases; Brain; Brain Ischemia; Cerebral Arterial Diseases; Contrast Media; Electroencephalography; Gadolinium DTPA; Male; Meglumine; Middle Cerebral Artery; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 2001 |
Comparative study between gadobenate dimeglumine and gadobutrol in rats with brain ischemia: evaluation of somatosensory evoked potentials.
Topics: Animals; Brain Ischemia; Contrast Media; Evoked Potentials, Somatosensory; Gadolinium; Iohexol; Male; Meglumine; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 2001 |
Intracranial lesion enhancement with gadolinium: T1-weighted spin-echo versus three-dimensional Fourier transform gradient-echo MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Brain Diseases; Brain Ischemia; Brain Neoplasms; Cerebrovascular Disorders; Contrast Media; Drug Combinations; Encephalitis; Female; Fourier Analysis; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1992 |
Evaluation of experimental early acute cerebral ischemia before the development of edema: use of dynamic, contrast-enhanced and diffusion-weighted MR scanning.
Topics: Acute Disease; Animals; Brain Edema; Brain Ischemia; Contrast Media; Dextrans; Drug Combinations; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pentetic Acid; Polylysine; Rats; Rats, Inbred SHR; Time Factors | 1992 |
Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Ischemia; Cerebral Arteries; Cerebrovascular Circulation; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1992 |